Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 28% ± 10% | |
GABAergic neuron | 3 studies | 32% ± 7% | |
glutamatergic neuron | 3 studies | 43% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 27% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1099.87 | 1445 / 1445 | 100% | 17.15 | 183 / 183 |
intestine | 100% | 1331.22 | 966 / 966 | 100% | 17.82 | 526 / 527 |
brain | 100% | 1396.05 | 2636 / 2642 | 100% | 11.96 | 705 / 705 |
breast | 100% | 1396.64 | 459 / 459 | 100% | 23.12 | 1114 / 1118 |
lung | 99% | 1033.73 | 575 / 578 | 100% | 12.59 | 1154 / 1155 |
stomach | 100% | 774.69 | 359 / 359 | 99% | 16.10 | 284 / 286 |
bladder | 100% | 1262.52 | 21 / 21 | 99% | 14.50 | 499 / 504 |
prostate | 100% | 923.85 | 245 / 245 | 98% | 12.79 | 494 / 502 |
ovary | 100% | 1385.85 | 180 / 180 | 98% | 7.52 | 422 / 430 |
kidney | 100% | 1200.76 | 89 / 89 | 98% | 14.04 | 882 / 901 |
adrenal gland | 100% | 1538.64 | 258 / 258 | 98% | 11.62 | 225 / 230 |
uterus | 100% | 1231.45 | 170 / 170 | 97% | 12.36 | 447 / 459 |
pancreas | 99% | 584.16 | 324 / 328 | 98% | 12.27 | 175 / 178 |
thymus | 100% | 1054.69 | 653 / 653 | 97% | 9.01 | 584 / 605 |
skin | 100% | 1531.27 | 1809 / 1809 | 93% | 12.91 | 438 / 472 |
liver | 100% | 975.96 | 226 / 226 | 89% | 7.61 | 362 / 406 |
adipose | 100% | 1210.58 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1085.76 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.84 | 1 / 1 |
blood vessel | 100% | 1174.69 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 581.65 | 792 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 12.84 | 43 / 45 |
heart | 93% | 531.03 | 803 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 9.58 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 68% | 5.41 | 54 / 80 |
peripheral blood | 48% | 574.46 | 445 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1900025 | Biological process | negative regulation of substrate adhesion-dependent cell spreading |
GO_0015031 | Biological process | protein transport |
GO_0034446 | Biological process | substrate adhesion-dependent cell spreading |
GO_0001920 | Biological process | negative regulation of receptor recycling |
GO_0034315 | Biological process | regulation of Arp2/3 complex-mediated actin nucleation |
GO_0048203 | Biological process | vesicle targeting, trans-Golgi to endosome |
GO_2000146 | Biological process | negative regulation of cell motility |
GO_0030133 | Cellular component | transport vesicle |
GO_0005768 | Cellular component | endosome |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005770 | Cellular component | late endosome |
GO_0005769 | Cellular component | early endosome |
GO_0035650 | Molecular function | AP-1 adaptor complex binding |
GO_0019894 | Molecular function | kinesin binding |
Gene name | AP1AR |
Protein name | AP-1 complex-associated regulatory protein (2c18) (Adaptor-related protein complex 1-associated regulatory protein) (Gamma-1-adaptin brefeldin A resistance protein) (GBAR) (Gamma-BAR) (Gamma-A1-adaptin and kinesin interactor) (Gadkin) Adaptor related protein complex 1 associated regulatory protein |
Synonyms | PRO0971 C4orf16 |
Description | FUNCTION: Necessary for adaptor protein complex 1 (AP-1)-dependent transport between the trans-Golgi network and endosomes. Regulates the membrane association of AP1G1/gamma1-adaptin, one of the subunits of the AP-1 adaptor complex. The direct interaction with AP1G1/gamma1-adaptin attenuates the release of the AP-1 complex from membranes. Regulates endosomal membrane traffic via association with AP-1 and KIF5B thus linking kinesin-based plus-end-directed microtubular transport to AP-1-dependent membrane traffic. May act as effector of AP-1 in calcium-induced endo-lysosome secretion. Inhibits Arp2/3 complex function; negatively regulates cell spreading, size and motility via intracellular sequestration of the Arp2/3 complex. . |
Accessions | H0Y8Y4 ENST00000309703.10 [Q63HQ0-2] ENST00000512741.1 Q63HQ0 ENST00000274000.10 [Q63HQ0-1] |